The Genomics, Genetics, and Epigenetics (GGE) Program is a preeminent national and international hub for groundbreaking cancer genomic and genetic/epigenetic research that makes field-changing discoveries, develops impactful novel analytical tools, and translates these discoveries into new therapies and diagnostic tests.
In collaboration with the program leaders — Lajos Pusztai, MD, DPhil, Jeffrey Townsend PhD, and Qin Yan, PhD — members of the GGE program study gene alterations in cancer with the goal of translating this knowledge into new drugs, novel therapeutic strategies, and novel diagnostic tests.